EARNEST Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $35.3M | Buy |
|
|||||
|
2024
Q4 | $54.5M | Buy |
|
|||||
|
2024
Q3 | $108M | Sell |
|
|||||
|
2024
Q2 | $99.6M | Buy |
|
|||||
|
2024
Q1 | $83.9M | Buy |
|
|||||
|
2023
Q4 | $74.9M | Buy |
|
|||||
|
2023
Q3 | $55.7M | Buy |
|
|||||
|
2023
Q2 | $75.4M | Buy |
|
|||||
|
2023
Q1 | $71.1M | Sell |
|
|||||
|
2022
Q4 | $47.9M | Sell |
|
|||||
|
2022
Q3 | $125M | Buy |
|
|||||
|
2022
Q2 | $117M | Buy |
|
|||||
|
2022
Q1 | $158M | Sell |
|
|||||
|
2021
Q4 | $174M | Buy |
|
|||||
|
2021
Q3 | $202M | Buy |
|
|||||
|
2021
Q2 | $189M | Sell |
|
|||||
|
2021
Q1 | $219M | Buy |
|
|||||
|
2020
Q4 | $133M | Buy |
|
|||||
|
2020
Q3 | $64.5M | Buy |
|
|||||
|
2020
Q2 | $54M | Buy |
|
|||||
|
2020
Q1 | $59.5M | Buy |
|
|||||
|
2019
Q4 | $98M | Buy |
|
|||||
|
2019
Q3 | $97M | Buy |
|